Abstract: A compressed powder body comprises metal particles and an interposed substance which is interposed between the metal particles. Each of the metal particles is made of FeSiAl-based soft magnetic alloy and has a flat shape when seen along a predetermined direction. The metal particles include one or more of the metal particles each of which is formed with one or more predetermined holes. Each of the predetermined holes passes through the metal particle in the predetermined direction. Each of the predetermined holes has a maximum width in a predetermined plane perpendicular to the predetermined direction the maximum width being equal to or larger than a thickness of the metal particle with the predetermined hole in the predetermined direction.

Abstract: A non-transitory computer-readable recording medium stores an information determination program causing a computer to execute a process including: classifying a plurality of sentences posted on the Internet into a plurality of clusters based on words contained in the plurality of sentences; extracting a topic from each of the plurality of clusters, the topic indicating a feature of a plurality of sentences included in the concerned cluster; for each of the plurality of clusters, determining a likelihood that a sentence about the topic newly posted on the Internet will turn to disinformation or misinformation based on an occurrence state of sentences considered as a factor for generating disinformation or misinformation in the plurality of sentences included in the concerned cluster; and outputting the topic associated with a cluster, the likelihood of turning of which satisfies a predetermined condition, among the plurality of clusters.

Abstract: A cooking apparatus includes a display unit and a display control unit configured to control the display unit. The display control unit controls the display unit to display an advertisement at a time when a user is likely to view a display screen of the display unit.

Abstract: The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to the patient simultaneously or sequentially a therapeutically effective amount of an EGFR kinase inhibitor and capecitabine combination, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of an EGFR kinase inhibitor and capecitabine combination in combination with a pharmaceutically acceptable carrier. A preferred example of an EGFR kinase inhibitor that can be used in practicing this invention is the compound erlotinib HCl (also known as TARCEVA®).